Amos J. Simon

Amos J. Simon

Auto-generated profile, based on publicly available information

Amos J. Simon

School of Medicine, Grey Faculty of Medical and Health Sciences Tel Aviv University Tel Aviv Israel

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2007 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
SSSigal Shaklai
Sigal Shaklai
NANinette Amariglio
Ninette Amariglio
GRGideon Rechavi
Gideon Rechavi
ASAmos J. Simon
Amos J. Simon
The nuclear envelope (NE) is composed of inner and outer nuclear membranes (INM and ONM, respectively), nuclear pore complexes and an underlying mesh like supportive structure – the lamina. It has long been known that heterochromatin clusters at the nuclear periphery adjacent to the nuclear lamina, hinting that proteins of the lamina may participate in regulation of gene expression. Recent studies on the molecular mechanisms involved show that proteins of the nuclear envelope participate in regulation of transcription on several levels, from direct binding to transcription factors to induction of epigenetic histone modifications. Three INM proteins; lamin B receptor, lamina‐associated polypeptide 2β and emerin, were shown to bind chromatin modifiers and/or transcriptional repressors inducing, at least in one case, histone deacetylation. Emerin and another INM protein, MAN1, have been linked to down‐regulation of specific signaling pathways, the retino blastoma 1/E2F MyoD and transforming growth factor beta/bone morphogenic protein, respectively. Therefore, cumulative data suggests that proteins of the nuclear lamina regulate transcription by recruiting chromatin modifiers and transcription factors to the nuclear periphery. In this minireview we describe the recent literature concerning mechanisms of gene repression by proteins of the NE and suggest the hypothesis that the epigenetic ‘histone code’, dictating transcriptional repression, is ‘written’ in part, at the NE by its proteins. Finally, as aberrant gene expression is one of the mechanisms speculated to underlie the newly discovered group of genetic diseases termed nuclear envelopathies/laminopathies, elucidating the repressive role of NE proteins is a major challenge to both researchers and clinicians.

1 May 2005 in Pediatric Research
Verified
Journal Article
Closed access
RSRaz Somech
Raz Somech
SSSigal Shaklai
Sigal Shaklai
NANinette Amariglio
Ninette Amariglio
GRGideon Rechavi
Gideon Rechavi
ASAmos J Simon
Amos J Simon

27 December 2018 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
NRNaama Rappoport
Naama Rappoport
ASAmos J. Simon
Amos J. Simon
NANinette Amariglio
Ninette Amariglio
GRGideon Rechavi
Gideon Rechavi

24 November 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ALAtar Lev
Atar Lev
YLYu Nee Lee
Yu Nee Lee
GSGuangping Sun
Guangping Sun
EHEnas Hallumi
Enas Hallumi
ASAmos J. Simon
Amos J. Simon
RSRaz Somech
Raz Somech
The T cell receptor (TCR) signaling pathway is an ensemble of numerous proteins that are crucial for an adequate immune response. Disruption of any protein involved in this pathway leads to severe immunodeficiency and unfavorable clinical outcomes. Here, we describe an infant with severe immunodeficiency who was found to have novel biallelic mutations in SLP76. SLP76 is a key protein involved in TCR signaling and in other hematopoietic pathways. Previous studies of this protein were performed using Jurkat-derived human leukemic T cell lines and SLP76-deficient mice. Our current study links this gene, for the first time, to a human immunodeficiency characterized by early-onset life-threatening infections, combined T and B cell immunodeficiency, severe neutrophil defects, and impaired platelet aggregation. Hereby, we characterized aspects of the patient's immune phenotype, modeled them with an SLP76-deficient Jurkat-derived T cell line, and rescued some consequences using ectopic expression of wild-type SLP76. Understanding human diseases due to SLP76 deficiency is helpful in explaining the mixed T cell and neutrophil defects, providing a guide for exploring human SLP76 biology.

22 October 2015 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
RMRuty Mehrian-Shai
Ruty Mehrian-Shai
MYMichal Yalon
Michal Yalon
ASAmos J. Simon
Amos J. Simon
EEEran Eyal
Eran Eyal
TPTatyana Pismenyuk
Tatyana Pismenyuk
ATAmos Toren
Amos Toren
Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor. Even with vigorous surgery, radiation and chemotherapy treatment, survival rates of GBM are very poor and predictive markers for prognosis are currently lacking. We performed whole genome expression studies of 67 fresh frozen untreated GBM tumors and validated results by 210 GBM samples’ expression data from The Cancer Genome Atlas. Here we show that in GBM patients, high metallothionein (MT) expression is associated with poor survival whereas low MT levels correspond to good prognosis. Furthermore we show that in U87 GBM cell line, p53 is found to be in an inactive mutant-like conformation concurrently with more than 4 times higher MT3 expression level than normal astrocytes and U251GBM cell line. We then show that U87- p53 inactivity can be rescued by zinc (Zn). Taken together, these data suggest that MT expression may be a potential novel prognostic biomarker for GBM, and that U87 cells may be a good model for patients with non active WT p53 resulting from high levels of MTs.

12 October 2016 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
ERErez Rechavi
Erez Rechavi
ALAtar Lev
Atar Lev
EEEran Eyal
Eran Eyal
OBOrtal Barel
Ortal Barel
NKNitzan Kol
Nitzan Kol
ASAmos J. Simon
Amos J. Simon